Objective: To define epidemiological and nosological structure of patients with chronic heart failure (CHF) according to hospitals of tertiary level of the Kyrgyz Republic (
Introduction
Heart failure can develop as a result of various diseases, damage of a myocardium of any etiology, arrhythmia and conduction disturbances, pathology of valves, pericardium diseases, etc., being the final stage practically of all diseases of cardiovascular system (1) (2) (3) (4) (5) (6) . In 1990, heart failure received definition of epidemic with steady growth (7, 8) . The prevalence of chronic heart failure (CHF) in the USA exceeds 5.8 million, and around the world -more than 23 million (8) . About 1-2% of adult population in the developed countries has CHF, with prevalence of risk >10% among patients aged older than 70 years (9) . The risk of emergence of heart failure at the age of 55 is present in 33% of men and 28% of women (9) . In addition, at present, it represents the serious problem of public healthcare related with the considerable incidence, mortality and expenses on healthcare, especially among people older than 65 years.
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According to the 2016 European recommendations on diagnosis and treatment of acute and chronic heart failure, coronary heart disease prevails as an etiological factor of CHF that corresponds to data of researches in the developed countries of North America (5) (6) (7) (8) (9) . According to studies the etiology of CHF is various among different regions of the world. Most of patients have in the anamnesis both the cardiovascular diseases and accompanying diseases capable to lead to CHF (9) . According to Belenkov et al. (3) , basic etiological reasons of development of CHF in the Russian Federation are arterial hypertension (AH) (88% of cases) and an ischemic heart disease (59% of cases). Stable angina pectoris shows high prevalence (51.3% of cases) in CHF, while myocardial infarction prevalence is lower (13.3% of cases) that is related to low efficacy of treatment of this complication and the remaining high myocardial infarction mortality (3, 10, 11) . The combination of an ischemic heart disease and AH exists in the majority of CHF population, at the same time acute myocardial infarction or acute coronary syndrome lead to development of heart failure in 15.3% (12) . Increase in number of patients with valvular heart diseases (VHD) (4.3%) with prevalence of degenerative defect of the aortic valve and decrease in number of rheumatic defects are noted (1). The majority of previous studies conducted in children described frequency and prevalence of the congenital heart diseases (CHD), but did not place emphasis on the heart failure in this category of patients (13) (14) (15) (16) (17) . The international Society on Transplantation of Heart and Lungs defines children's heart failure as "the clinical and pathophysiological syndrome resulting from dysfunction of ventricles, volume or an overload pressure, separately or in a combination`` (16) . In children, it results in characteristic signs and symptoms, such as poor growth, problems with nutrition, respiratory insufficiency, intolerance to exercise stress and fatigue, and is connected with blood circulation disturbances, neuro-hormonal and molecular disturbances (16) .
In the United States, complex epidemiological studies on heart failure in pediatric population (16) were not reported. In the territory of Europe, two such studies were conducted (14, 15) . In these studies, differences in the frequency of CHF in their populations were observed: one research revealed cardiovascular diseases in 10.4% including patients with congenital and acquired heart diseases, and anothercardiovascular diseases in 34%; and in CHD populations the frequency of heart failure was 6.2% and 39%, respectively (14, 15) . The main etiological reasons were more dependent on age of children: so, until 1 year, there was more CHD; in children of advanced age, the reasons of development of heart failure along with CHD were disturbances of heart rhythm, cardiomyopathy, and VHD (14-17). Cardiovascular diseases even more often are recognized as the important reason of incidence and mortality in developing countries. As the countries undergo epidemiological transition and social and economic development, the epidemiology of heart failure becomes more and more similar to a situation of countries of Western Europe and North America where coronary artery disease (CAD) is the only most common cause of heart failure (5, 10). Callender et al (10) , in his systematic review and meta-analysis analyzed 230,000 cases of CHF from 31 countries and revealed that heart failure is already the main burden for the population and health services in the countries with the low and middle level of income providing patient treatment to only 2.2% of cases (10) . There are no data on carrying out studies of CHF in pediatric category of patients in developing countries.
In the territory of Kyrgyzstan, large-scale and system researches on epidemiological and nosological structure of CHF at the level of institutions of tertiary level were never conducted and basic reasons of its development are not certain. It is probable that in line with AH, CAD and diabetes, rheumatic heart diseases, myocarditis, CHD takes not the last place in development of CHF. We used descriptive statistics to present data, expressed in number and percentages.
Results
According to research objective in the period of 2017 -2018 in the NCCT and SRIHSOT 25415 patients medical records were studied and analyzed (Table 1) : 12736 in the year 2017 and 12679 in the year 2018. The basic etiological reason of CHF development in adult patients with FC -I-II is CAD in 33.00% of cases (Table 4 ). In addition, frequent reasons of development of CHF became diabetes mellitus in 3.94% of patients and AH -in 3.69% of patients.
Attracts attention that in more than a half of cases -58.09% the etiological reasons of development of CHF were other reasons, not being classical, it is probable due to younger age of this category of patients. As it is provided in Table 6 , among referred to SRIHSOT patients, occurrence of pulmonary vein stenosis (4.6%) and tetralogy of Fallot (3.8%) attracted attention. Defects with more than 1.0% of frequency were represented by combined anomalies of septal defects (3.4%), ASD with ductus arteriosus (DA) (1.7%), VSD with PDA (1.3%), VSD with pulmonary vein stenosis (PVS) (0.7%), and AV septal defect (1.0%). The degree of pulmonary hypertension was defined according to pulmonary arterial pressure levels. 4%) ), isolated or local were seen less often (35 (7.7%)). By the form the affected valve, the following forms were allocated: aortic (207), mitral (297), tricuspid (196), pulmonary (4). According to hemodynamics, patients were distributed as following: compensated VHD was recorded in 171 (37.7%), subcompensated -221 (48.8%), and decompensated -61 (13.5%). In total, 140 patients (30.9%) were operated. Closed mitral commissurotomy was performed in 15 (3.3%) cases, mitral valve replacement -in 77 (16.9%) patients, mitral and aortic valve replacements -in 20 (4.4%) patients, mitral, aortic and tricuspid valves replacements were carried out in 4 (0.9%) patients, mitral and tricuspid valves replacements -in 18 (3.9%) of patients, aortic valve replacement -in 1 (0.2%) patient, and tricuspid valve replacement -in 1 (0.2%) patient. 
